- Home
- KEQU vs VSTM Comparison
KEQU vs VSTM Comparison
Compare KEQU & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEQU
- VSTM
- Stock Information
- Founded
- KEQU 1906
- VSTM 2010
- Country
- KEQU United States
- VSTM United States
- Employees
- KEQU N/A
- VSTM N/A
- Industry
- KEQU Medical Specialities
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- KEQU Industrials
- VSTM Health Care
- Exchange
- KEQU Nasdaq
- VSTM Nasdaq
- Market Cap
- KEQU 154.8M
- VSTM 132.0M
- IPO Year
- KEQU N/A
- VSTM 2012
- Fundamental
- Price
- KEQU $43.70
- VSTM $4.00
- Analyst Decision
- KEQU
- VSTM Strong Buy
- Analyst Count
- KEQU 0
- VSTM 8
- Target Price
- KEQU N/A
- VSTM $14.57
- AVG Volume (30 Days)
- KEQU 13.9K
- VSTM 985.6K
- Earning Date
- KEQU 12-04-2024
- VSTM 11-06-2024
- Dividend Yield
- KEQU N/A
- VSTM N/A
- EPS Growth
- KEQU 359.78
- VSTM N/A
- EPS
- KEQU 6.24
- VSTM N/A
- Revenue
- KEQU $202,309,000.00
- VSTM $10,000,000.00
- Revenue This Year
- KEQU N/A
- VSTM N/A
- Revenue Next Year
- KEQU N/A
- VSTM $108.05
- P/E Ratio
- KEQU $7.00
- VSTM N/A
- Revenue Growth
- KEQU N/A
- VSTM N/A
- 52 Week Low
- KEQU $16.51
- VSTM $2.10
- 52 Week High
- KEQU $55.62
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- KEQU 73.35
- VSTM 56.35
- Support Level
- KEQU $41.88
- VSTM $3.72
- Resistance Level
- KEQU $44.54
- VSTM $4.15
- Average True Range (ATR)
- KEQU 1.84
- VSTM 0.37
- MACD
- KEQU 0.84
- VSTM -0.04
- Stochastic Oscillator
- KEQU 91.16
- VSTM 39.39
About KEQU Kewaunee Scientific Corporation
Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company operates through two segments: Domestic and International. The Domestic business segment designs manufacture and install scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International business segment provides facility design, engineering, construction and project management from the planning stage through the testing and commissioning of laboratories. The company generates a majority of its revenue from the Domestic business segment.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.